Scancell Holdings Plc Company Profile (LON:SCLP)

Analyst Ratings

Consensus Ratings for Scancell Holdings Plc (LON:SCLP) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: GBX 68

Analysts' Ratings History for Scancell Holdings Plc (LON:SCLP)
Show:
DateFirmActionRatingPrice TargetActions
7/20/2016Panmure GordonReiterated RatingBuyGBX 68View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Scancell Holdings Plc (LON:SCLP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Scancell Holdings Plc (LON:SCLP)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Scancell Holdings Plc (LON:SCLP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Scancell Holdings Plc (LON:SCLP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Scancell Holdings Plc (LON:SCLP)
DateHeadline
07/22/16 09:15 AMScancell turns to Belgian group to replenish vaccine stocks
07/21/16 06:39 PMRisers and fallers, including Anglo American, IronRidge Resources and Firestone Diamonds - Proactive Investors USA & Canada
07/21/16 06:39 PMScancell turns to Belgian group to replenish vaccine stocks - Proactive Investors UK
07/21/16 06:39 PMScancell Holdings PLC (LON:SCLP) stock price target held steady at 68GBX as disclosed today by Panmure Gordon - Breaking Finance News
07/20/16 07:12 PMScancell Holdings PLC (LON:SCLP) stock price target held steady at 68GBX as disclosed today by Panmure Gordon
07/20/16 09:11 AMScancell extends commercial licence with Ichor
07/13/16 09:14 AMScancell’s cancer vaccine programme boosted by scientific review
07/07/16 06:23 PMIs Selling Stock Like Scancell Holdings Plc After Such Decline Winning Strategy? - Engelwood Daily
07/07/16 06:23 PMShares Of Scancell Holdings PLC (LON:SCLP) Rated As Buy By Analysts At Panmure Gordon - Fiscal Standard
07/06/16 06:40 PMFTSE 100 down 0.2% on open - Proactive Investors UK
07/06/16 06:40 PMFTSE 100 Index rises but pound slumps on 'Brexit' fears - Proactive Investors UK
07/06/16 06:40 PMScancell Holdings says SCIB1 survival data is compelling - Proactive Investors UK
07/06/16 10:56 AMScancell Holdings says SCIB1 survival data is compelling
07/06/16 04:01 AMSCIB1 continues to deliver compelling survival data in melanoma - [at noodls] - Scancell to present update at the Oxford Technology VCT AGM and Proactive Investors One2One Forum Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment ...
07/04/16 10:52 AMScancell Holdings (LON:SCLP) Analyst Target Changes - Fiscal Standard
06/25/16 05:43 PMScancell Holdings (LON:SCLP) Broker Updates - Fiscal Standard
06/18/16 10:25 AMSCIB1 Drug Product Supply
06/17/16 09:00 AMScancell's SCIB1 offers patient opportunities - Panmure's Mitchell
06/17/16 09:00 AMScancell working quickly to secure new supplies of drug
06/17/16 09:00 AMPanmure Gordon covered (LON:SCLP) Scancell Holdings PLC, sustaining its target price to GBX68 earlier today
06/17/16 03:10 AMScancell slumps as drug problem disrupts melanoma trial -
06/17/16 02:46 AMBUZZ-Scancell: drug problem spurs worst day in 3 yrs -
06/17/16 01:51 AMDrug problem forces Scancell to suspend cancer trial dosing -
06/02/16 09:24 AMScancell's immunotherapy platform to fight brain cancer - Proactive Investors UK - Proactive Investors UKScancell's immunotherapy platform to fight brain cancerProactive Investors UKScancell Holdings Plc (LON:SCLP) technology is being used to develop a vaccine for the treatment of one of the most common and most aggressive forms of brain cancer. Researchers at Nottingham Trent University and the University of Portsmouth have ...and more »
05/24/16 12:33 PMDavid Kempton: 5 stocks I'm buying as EU vote looms - Citywire.co.uk - Citywire.co.ukDavid Kempton: 5 stocks I'm buying as EU vote loomsCitywire.co.ukThese trades are not looking good with equities holding up well enough and the pound getting stronger. Is there a growing belief that Brexit will not ... At the next lunch in early June, I plan to present Scancell (SCLP), a 'blue sky' biotech. These ...and more »
05/24/16 12:33 PMScancell Holdings (LON:SCLP) New Price Targets - FTSE News - Scancell Holdings (LON:SCLP) New Price TargetsFTSE NewsRecently stock market broker analysts have updated their ratings and price targets on shares of Scancell Holdings (LON:SCLP). The latest broker reports ... Scancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops ...and more »
05/20/16 12:18 PMFTSE 100 Index falls but Goals Soccer Centres scores high - Proactive Investors UK - Proactive Investors UKFTSE 100 Index falls but Goals Soccer Centres scores highProactive Investors UKInvestors also piled into Scancell Holdings Plc (LON:SCLP), the cancer vaccine specialist, by 9% to 16.63p. The company signalled its intent to expand in the US by opening new offices in San Diego. But DX (Group) PLC (LON:DX.) headed the other way, ...and more »
05/20/16 12:18 PMSyndicateRoom stands out from the crowd with its investor-led approach - Proactive Investors USA & Canada - Proactive Investors USA & CanadaSyndicateRoom stands out from the crowd with its investor-led approachProactive Investors USA & CanadaIt recently helped bring in new shareholders for a stock placing that raised £3mln for the immuno-oncology firm Scancell Holdings (LON:SCLP). Small investors tend to be locked out of these deals, which offer the City institutions and other professional ...and more »
05/20/16 12:18 PMRisers & Fallers: Scancell Holdings, Asian Citrus Holdings and more - Proactive Investors UK - Proactive Investors UKRisers & Fallers: Scancell Holdings, Asian Citrus Holdings and moreProactive Investors UKReach4Entertainment Enterprises PLC (LON:R4E) , up over 24% to 2.15p after Gate Ventures increased its stake in the entertainment advertising and marketing company to above 17% on May 17. Scancell Holdings Plc (LON:SCLP), the cancer vaccine ...and more »
05/19/16 11:54 AMScancell undergoes management reshuffle - Scancell Holdings Plc (LON:SCLP) is set for a management reshuffle to support its ambitious growth plans. Dr Richard Goodfellow, currently joint-CEO, will be appointed chief executive officer. Professor Lindy Durrant will step down from her role as joint ...
05/18/16 12:38 PMRisers & Fallers: Burberry, Dunelm, Strategic Minerals and more - Proactive Investors UK - Proactive Investors UKRisers & Fallers: Burberry, Dunelm, Strategic Minerals and moreProactive Investors UKReach4Entertainment Enterprises PLC (LON:R4E) , up over 24% to 2.15p after Gate Ventures increased its stake in the entertainment advertising and marketing company to above 17% on May 17. Scancell Holdings Plc (LON:SCLP), the cancer vaccine ...and more »
05/18/16 12:38 PMPanmure Gordon Reiterated Scancell Holdings PLC (LON:SCLP) As 'Buy' - Share Trading News - Share Trading NewsPanmure Gordon Reiterated Scancell Holdings PLC (LON:SCLP) As 'Buy'Share Trading NewsScancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops immunotherapies based on its ImmunoBody and Moditope technology platforms. Its ImmunoBody, SCIB1, is being developed for treatment of melanoma ...Scancell Holdings Plc 277.8% Potential Upside Indicated by Panmure GordonDirectorsTalk InterviewsScancell Holdings PLC (LON:SCLP) Investors: Panmure Gordon Keeps Buy Rating, Sees GBX 68.00/ShareWall Street Hints and NewsPanmure Gordon Indicates Potential 338.85% Increase In Shares Of Scancell Holdings PLCRisers & Fallersall 20 news articles »
05/18/16 04:32 AMScancell Opens US Headquarters in San Diego - Key Management Changes to Support Future Growth - [at noodls] - Scancell Holdings Plc, (AIM:SCLP), today announces the opening of new offices in San Diego to support the Company's ambitious US growth plans together with plans to establish a new base in the Oxford area ...
05/10/16 06:17 AMNew Analyst Ratings For Scancell Holdings (LON:SCLP) - Share Trading News - New Analyst Ratings For Scancell Holdings (LON:SCLP)Share Trading NewsA number of investment brokers have recently updated their price targets on shares of Scancell Holdings (LON:SCLP). According to the latest broker ... Scancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops ...and more »
04/28/16 06:14 AMOutstanding Analyst Ratings For Scancell Holdings (LON:SCLP) - FTSE News - Outstanding Analyst Ratings For Scancell Holdings (LON:SCLP)FTSE NewsNumerous investment brokers have in recent days changed their price targets on shares of Scancell Holdings (LON:SCLP). According to data retrieved from Reuters, on Wednesday 27th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...and more »
04/26/16 06:46 AMScancell Holdings (LON:SCLP) Broker Roundup - Share Trading News - Scancell Holdings (LON:SCLP) Broker RoundupShare Trading NewsRecently stock market analysts have updated their consensus ratings on shares of Scancell Holdings (LON:SCLP). The latest broker reports which are currently outstanding on Tuesday 26th of April state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
04/15/16 10:04 AMCould Scancell Holdings Plc See a Reversal After This Very Weak Session? - Clinton Financial - Clinton FinancialCould Scancell Holdings Plc See a Reversal After This Very Weak Session?Clinton FinancialThe stock of Scancell Holdings Plc (LON:SCLP) is a huge mover today! The stock decreased 3.65% or GBX 0.62 on April 14, hitting GBX 16.5. About 250,548 shares traded hands or 12.13% up from the average. Scancell Holdings Plc (LON:SCLP) has ...
04/09/16 09:24 AMScancell Holdings Share Chat - scancellPrivate equity fund manager and Enterprise Investment Scheme specialist Calculus Capital has invested £2.4m in a new fundraising by AIM-listed portfolio company Scancell Holdings plc. Calculus’s latest funding contributed to a total of £6.2m ...
04/06/16 12:02 PMWeekly Broker Update - Scancell Holdings (LON:SCLP) - Risers & Fallers - Weekly Broker Update - Scancell Holdings (LON:SCLP)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Scancell Holdings (LON:SCLP). The latest broker reports which are ... Scancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops ...and more »
04/02/16 10:26 AMSyndicateRoom's crowdfunding for AIM's Scancell marks significant milestone - Proactive Investors USA & Canada - Proactive Investors USA & CanadaSyndicateRoom's crowdfunding for AIM's Scancell marks significant milestoneProactive Investors USA & CanadaScancell Holdings Plc's (LON:SCLP) successful £6.1mln share placing is particularly significant as it marks the first time - via crowdfunding - that retail investors have been able to access an AIM company raise on the same terms as City institutions ...and more »
04/02/16 10:26 AMScancell Holdings Plc's (SCLP) Under Review Rating Reaffirmed at Panmure Gordon - MicroCap Magazine - Proactive Investors USA & CanadaScancell Holdings Plc's (SCLP) Under Review Rating Reaffirmed at Panmure GordonMicroCap MagazineScancell Holdings Plc logo Scancell Holdings Plc (LON:SCLP)'s stock had its “under review” rating restated by investment analysts at Panmure Gordon in a research report issued on Friday, MarketBeat.com reports. Scancell Holdings Plc (LON:SCLP) opened ...Scancell Holdings Plc (SCLP) Earns Under Review Rating from Panmure GordonSouth Florida Hedge Fund ManagersScancell Holdings PLC 'delighted' with success of £6.1mln fundraiserProactive Investors USA & CanadaWhat Next for Scancell Holdings Plc Stock After Today's Huge Increase?Stock CallerProactive Investors UKall 7 news articles »
04/01/16 11:55 AMProactive news summary: Keywords Studios PLC, Scancell Holdings PLC, Metal Tiger PLD and more - Proactive Investors UK - Proactive Investors UKProactive news summary: Keywords Studios PLC, Scancell Holdings PLC, Metal Tiger PLD and moreProactive Investors UKElsewhere, Scancell Holdings PLC (LON:SCLP) successfully raised £6.1mln via a placing and open offer of shares with new and existing investors. The cash will be used to accelerate the development of its cancer-fighting immunotherapies. Over at Anglo ...and more »
03/31/16 12:33 PMAnalysts Consensus For Scancell Holdings (LON:SCLP) - Risers & Fallers - Analysts Consensus For Scancell Holdings (LON:SCLP)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Scancell Holdings (LON:SCLP). According to the latest broker ... Scancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops ...
03/27/16 01:31 PMScancell Holdings Plc (SCLP) Given “Under Review” Rating at Panmure Gordon - MicroCap Magazine - Scancell Holdings Plc (SCLP) Given “Under Review” Rating at Panmure GordonMicroCap MagazineScancell Holdings Plc (LON:SCLP)'s stock had its “under review” rating reaffirmed by research analysts at Panmure Gordon in a research note issued on Wednesday, ARN reports. Shares of Scancell Holdings Plc (LON:SCLP) traded up 0.28% during mid-day ...and more »
03/25/16 12:22 PMScancell Holdings PLC to present at World Vaccine Congress - Proactive Investors UK - Proactive Investors UKScancell Holdings PLC to present at World Vaccine CongressProactive Investors UKScancell Holdings PLC's (LON:SCLP) Dr Peter Brown is to present an update on the company's SCIB1 ImmunoBody cancer vaccine at this year's World Vaccine Congress. The presentation, entitled: "SCIB1 ImmunoBody stimulates a potent T cell response ...Outstanding Analyst Ratings For Scancell Holdings (LON:SCLP)FTSE Newsall 5 news articles »
03/24/16 01:05 PMProactive news summary: Akers Biosciences Inc, Cluff Natural Resources PLC, Fastjet PLC and more - Proactive Investors UK - Proactive Investors UKProactive news summary: Akers Biosciences Inc, Cluff Natural Resources PLC, Fastjet PLC and moreProactive Investors UKAnd finally, Scancell Holdings PLC's (LON:SCLP) Dr Peter Brown is to present an update on the company's SCIB1 ImmunoBody cancer vaccine at this year's World Vaccine Congress in Washington DC. The presentation is entitled: "SCIB1 ImmunoBody ...and more »
03/21/16 12:45 PMScancell Holdings (LON:SCLP) Broker Updates - Share Trading News - Scancell Holdings (LON:SCLP) Broker UpdatesShare Trading NewsScancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops immunotherapies based on its ImmunoBody and Moditope technology platforms. Its ImmunoBody, SCIB1, is being developed for treatment of melanoma ...and more »
03/12/16 11:11 AMScancell Holdings Plc Has Another Very Strong Trading Session - Stock Caller - Scancell Holdings Plc Has Another Very Strong Trading SessionStock CallerThe stock of Scancell Holdings Plc (LON:SCLP) is a huge mover today! The stock increased 8.15% or GBX 1.43 on March 11, hitting GBX 19. About 249,541 shares traded hands or 63.57% up from the average. Scancell Holdings Plc (LON:SCLP) has ...
03/11/16 12:36 PMRisers & Fallers, including Software Radio Technology PLC, Imaginatik plc, Prudential PLC... - Proactive Investors UK - Risers & Fallers, including Software Radio Technology PLC, Imaginatik plc, Prudential PLC...Proactive Investors UKThe accident prone security and services group posted pre-tax profits of £78mln, down from £128mln, with revenues slightly lower at £6.86bn. Scancell Holdings PLC (LON:SCLP) down 14% to 17.4p. Immunotherapy group raises £6.8mlm at 17p to support ...and more »
03/11/16 12:36 PMThe Footsie rockets higher, overshadowing Aim's rise - Proactive Investors UK - Proactive Investors UKThe Footsie rockets higher, overshadowing Aim's riseProactive Investors UKDrug developer Scancell Holdings PLC (LON:SCLP) advanced almost 8% to 19p as it said it is teaming up with Sweden's leading research organisation. The collaboration could aid the development of one of Scancell's two breakthrough technologies.

Social

About Scancell Holdings Plc

Scancell Holdings Plc logoScancell Holdings plc develops immunotherapies for the treatment of cancer. The Company develops immunotherapies based on its ImmunoBody and Moditope technology platforms. Its ImmunoBody, SCIB1, is being developed for treatment of melanoma and is being evaluated in Phase I/II clinical trial. Its clinical trials demonstrated that SCIB1, when used as monotherapy, has an effect on tumor load, produces a melanoma-specific immune response and survival trend without serious side effects. Its ImmunoBody vaccines target dendritic cells and stimulate both parts of the cellular immune system: the helper cell system, where inflammation is stimulated at the tumor site and the cytotoxic T-lymphocyte response, where immune system cells are primed to recognize and kill specific cells. The Moditope immunotherapy platform is based on exploiting the normal immune response to stressed cells, mediated by cluster of differentiation 4+ T cells, and harnessing this mechanism to eradicate cancer cells.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: SCLP
  • CUSIP:
Key Metrics:
  • Previous Close: $0.25
  • 50 Day Moving Average: $17.3547
  • 200 Day Moving Average: $17.5709
  • P/E Ratio: N/A
  • P/E Growth: 0.0000
  • Market Cap: $40.99M
  • Current Year EPS Consensus Estimate: $-1.20 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: